The week’s best shares

Centamin The Sunday Times

The gold miner had a disappointing 2018. But, with a refreshed board, it is “turning a corner” as output recovers and the gold price rallies. Panmure Gordon gives a 140p price target. Buy. 118p.

Glaxosmithkline The Daily Telegraph

GSK’S split into two businesses – a consumer healthcare firm (a new joint venture with Pfizer) and a separate drug arm – should mean gains for investors. The former’s healthy margins and strong cash flow can support its high debt. Yields 5.5%. Buy. £14.52.

Investors Chronicle

The chocolatier is being driven forward by a combination of strong online traction, new UK store openings and international growth. Increased capacity should boost margins and the brand. Debt-free with good cash flow. Buy. 305p.

Inchcape The Times

This new and used car retailer is the exclusive distributor for Toyota, Lexus and Suzuki in Asia, where it operates on 10.9% margins. Cash generative and undervalued, with an estimated 4.7% yield. Buy. 573p.

The Sunday Telegraph

This catalytic converter specialist’s hot new product is ELNO (enhanced lithium nickel oxide) – which holds out the promise of cheap, high-density car batteries and power cells. Not risk-free, but fairly valued with a good record. Buy. £30.45.

Onesavings Bank The Daily Telegraph

Despite the woes of rival Metro Bank, this challenger is worth a look. Lowly valued, with expected single-digit earnings growth and a 3.7% yield. Strong capital reserves help offset risks. Buy. 386p.